Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management
NCT04343092
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
COVID 19
Interventions
DRUG:
Ivermectin (IVM)
Sponsor
University of Baghdad